INS and type 2 diabetes mellitus: Self-monitoring blood glucose (SMBG) improves glycaemic control in patients with type 1 diabetes [1] and possibly also in insulin-treated type 2 diabetes (T2D) [2], especially when treated with multiple insulin injections per day [3].